EUVIMEDEUVIMED entdecken
Crossref

An inhibitory immunoreceptor Allergin-1 regulates the intestinal dysbiosis and barrier function in mice

Yu-Hsien Lin, Satoko Tahara-Hanaoka iD, Nozomu Obana, Shinji Fukuda, Akira Shibuya

International Immunology · 2024

DOI: 10.1093/intimm/dxae010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunology, 2024. Verfasst von Yu-Hsien Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan. Hauptthemen laut MEDLINE: Dysbiosis, Mice, Knockout, Intestinal Mucosa, Mice, Inbred C57BL. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Food Science Institute Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The intestinal barrier consists of mucosal, epithelial, and immunological barriers and serves as a dynamic interface between the host and its environment. Disruption of the intestinal barrier integrity is a leading cause of various gastrointestinal diseases, such as inflammatory bowel disease. The homeostasis of the intestinal barrier is tightly regulated by crosstalk between gut microbes and the immune system; however, the implication of the immune system on the imbalance of gut microbes that disrupts barrier integrity remains to be fully elucidated. An inhibitory immunoglobulin-like receptor, Allergin-1, is expressed on mast cells and dendritic cells and inhibits Toll-like receptor (TLR)-2 and TLR-4 signaling in these cells. Since TLRs are major sensors of microbiota and are involved in local epithelial homeostasis, we investigated the role of Allergin-1 in maintaining intestinal homeostasis. Allergin-1-deficient (Milr1−/−) mice exhibited more severe dextran sulfate sodium (DSS)-induced colitis than did wild-type (WT) mice. Milr1−/− mice showed an enhanced intestinal permeability compared with WT mice even before DSS administration. Treatment of Milr1−/− mice with neomycin, but not ampicillin, restored intestinal barrier integrity. The 16S rRNA gene sequencing analysis demonstrated that Bifidobacterium pseudolongum was the dominant bacterium in Milr1−/− mice after treatment with ampicillin. Although the transfer of B. pseudolongum to germ-free WT mice had no effect on intestinal permeability, its transfer into ampicillin-treated WT mice enhanced intestinal permeability. These results demonstrated that Allergin-1 deficiency enhanced intestinal dysbiosis with expanded B. pseudolongum, which contributes to intestinal barrier dysfunction in collaboration with neomycin-sensitive and ampicillin-resistant microbiota.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DysbiosisMice, KnockoutIntestinal MucosaMice, Inbred C57BLAnimalsMiceDextran SulfateGastrointestinal MicrobiomeColitisReceptors, ImmunologicNeomycinPermeability

Stichwörter der Autor:innen

Bifidobacterium pseudolongum16S rRNA gene sequencingDSS-induced colitis

Substanzen

Dextran SulfateReceptors, ImmunologicNeomycin

Autor:innen und Institutionen

  • Department of Immunology, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance (TARA), University of Tsukuba, Tsukuba, Japan.
  • R&D Center for Innovative Drug Discovery, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.
  • Transborder Medical Research Center, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Microbiology Research Center for Sustainability, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Institute for Advanced Biosciences, Keio University, Tsuruoka, Japan.

ORCID-Profile: Satoko Tahara-Hanaoka

Förderung

  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development
  • Food Science Institute Foundation

Zitieren

APA

Lin, Y. H., Tahara-Hanaoka, S., Obana, N., Fukuda, S., & Shibuya, A. (2024). An inhibitory immunoreceptor Allergin-1 regulates the intestinal dysbiosis and barrier function in mice. International Immunology. https://doi.org/10.1093/intimm/dxae010

Vancouver

Lin YH, Tahara-Hanaoka S, Obana N, Fukuda S, Shibuya A. An inhibitory immunoreceptor Allergin-1 regulates the intestinal dysbiosis and barrier function in mice. International Immunology. 2024. doi:10.1093/intimm/dxae010

BibTeX
@article{Lin2024,
  author = {Lin, Yu-Hsien and Tahara-Hanaoka, Satoko and Obana, Nozomu and Fukuda, Shinji and Shibuya, Akira},
  title = {An inhibitory immunoreceptor Allergin-1 regulates the intestinal dysbiosis and barrier function in mice},
  journal = {International Immunology},
  year = {2024},
  doi = {10.1093/intimm/dxae010}
}
Kostenlos starten →